SIDE EFFECTS OF SGLT-2 INHIBITORS IN PATIENTS WITH HEART FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Anno:
2023
Background: sodium-glucose cotransoporter-2 inhibitors (SGLT-2Is) improve prognosis in heart failure patients both with reduced (HFrEF) and preserved ejection fraction (HFpEF). However, these drugs can have some side effects. Purpose: estimate the relative risk of side effects in HF patients treated with SGLT-2Is irrespectively from left ventricular EF and setting…